Overview
Updated 14 Jul 2026
David A. Reardon is Clinical Director, Center for Neuro-Oncology, Dana-Farber Cancer Institute. The public record shows 1,226 publications with 63,926 citations (h-index 121), centered on Glioma Diagnosis and Treatment, Cancer Immunotherapy and Biomarkers, Brain Metastases and Treatment. It also documents an investigator role on 28 registered clinical trials, industry payments reported by 11 companies, 1 NIH-funded awards (2020–2024).
- Most recent indexed publication: 2026 · Nature cancer
- Top research focus: Glioma Diagnosis and Treatment
- 28 registered trials on ClinicalTrials.gov
- Open Payments reporting from 11 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 42 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 454.
Clinical & industrytrials, payments and federal funding
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 28 registered studies on ClinicalTrials.gov. The most recent:
- SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
Sponsor: Nuvation Bio Inc.
InvestigatorPhase 3RecruitingNCT05303519 - ASP8374 + Cemiplimab in Recurrent Glioma
Sponsor: Dana-Farber Cancer Institute
InvestigatorPhase 1CompletedNCT04826393
Industry payments
Updated 14 Jul 2026
11 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Boehringer Ingelheim RCV GmbH & Co KGProgram year20253 payments
- Nuvation Bio Inc.Program year20251 payment
- SERVIER PHARMACEUTICALS LLCProgram year20249 payments$15,073openpaymentsdata.cms.gov ↗
NIH funding
Updated 14 Jul 2026
1 NIH research award on record, funded 2020–2024 per NIH RePORTER. The latest:
- Understanding and Overcoming T cell Immunosuppression in Glioblastoma
Brigham and Women'S Hospital
FY2024$2,680,832P01CA236749 - Proj. 1 Targeting Tumor-Specific Neoepitopes for Glioblastoma Immunotherapy
Brigham and Women'S Hospital
FY2024$503,520P01CA236749 - Understanding and Overcoming T cell Immunosuppression in Glioblastoma
Brigham and Women'S Hospital
FY2023$2,810,976P01CA236749
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- A 10-year-long ongoing complete response to vismodegib as first-line treatment in adult metastatic medulloblastoma.
Acta oncologica (Stockholm, Sweden)
2026
Most-cited worksby citation count (OpenAlex)
- 01<i>IDH1</i>and<i>IDH2</i>Mutations in Gliomas5,933 citations2009
- 02
- 03Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma1,462 citations2020
- 04
- 05
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Network
Updated 14 Jul 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- Fellowship
Pediatric Hematology/Oncology, University of Michigan Hospital/C.S. Mott Children's Hospital
1992verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dana-farber.org ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dana-farber.org ↗
- Residency
Pediatrics, Johns Hopkins Hospital
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dana-farber.org ↗ - Board Certified
Neuro-Oncology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dana-farber.org ↗ - Board Certified
Pediatric Hematology/Oncology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dana-farber.org ↗
Editorial & leadership rolesjournal and society appointments
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dfhcc.harvard.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hstalks.com ↗
- Clinical Director
Center for Neuro-Oncology, Dana-Farber Cancer Institute
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dfhcc.harvard.edu ↗
Awards & honorshonors on the public record
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →dana-farber.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dana-farber.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dana-farber.org ↗
Secondary affiliationsappointments beyond the home institution
- Scientific/Medical Advisory Board Member
Vivacitas Oncology Inc (Neuro-Oncology Medical Advisory Board)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vivaoncology.com ↗ - Scientific Advisory Board
Immunomic Therapeutics
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →immunomix.com ↗ - Scientific Advisory Board
Stemline Therapeutics
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ir.stemline.com ↗
Media & interviewspress, podcasts and appearances
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ascopost.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- Doximity
doximity.com/pub/david-reardon-md-30ab18ab
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - ResearchGate
researchgate.net/scientific-contributions/David-A-Reardon-39924843
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by otherswhere others cite or feature them
- LinkedIn
linkedin.com/posts/dana-farber-cancer-institute_david-reardon-md-is-doing-a-deep-dive-into-activity-7213874102464299008-IUaK
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗ - X / Twitter
x.com/TargetedOnc/status/693652538143457281
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗ - YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Paul Richardson, MD
Harvard University
- 2,062
- publications
- 172
- h-index
- 17
- trials
Pasi Janne, MD, PhD
Harvard University
- 2,385
- publications
- 163
- h-index
- 15
- trials
Steven Greenberg, MD
Harvard University
- 954
- publications
- 144
- h-index
- 9
- trials
David Scadden, MD
Harvard University
- 665
- publications
- 124
- h-index
- 4
- trials